Burning Rock Biotech Limited (BNR)
Nasdaq: BNR · Services-Medical Laboratories · Guangzhou, Guangdong, CN · filing with the SEC since 2019
Who runs Burning Rock Biotech Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedOfficers reporting now
1
of 6 people with a filing in the last fifteen months
Directors reporting now
5
6 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Hu Xiaozhi | Senior Director in Finance | Mar 2026 | Mar 17, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Han Yusheng | director | Mar 2026 | Jul 2, 2026 | none |
| Deng Feng | director | Mar 2026 | Mar 18, 2026 | none |
| Hayes Wendy W. | director | Mar 2026 | Mar 17, 2026 | none |
| Xu Licen Lisa | director | Mar 2026 | Mar 17, 2026 | none |
| Zhang Zhihong | director | Mar 2026 | Mar 17, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.